Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.
Ren S, Xu C, Cui Z, Yu Y, Xu W, Wang F, Lu J, Wei M, Lu X, Gao X, Liang Y, Mao JH, Sun Y.
Ren S, et al. Among authors: sun y.
J Mol Med (Berl). 2012 Oct;90(10):1121-32. doi: 10.1007/s00109-012-0885-0. Epub 2012 Mar 16.
J Mol Med (Berl). 2012.
PMID: 22422151
Free PMC article.